Abstract
The management of acute otitis media (AOM) in childhood has evolved considerably during recent years as a result of the new insights provided by publication (in 2004) of the American Academy of Pediatrics and the American Academy of Family Physicians guidelines for the treatment of AOM. The new treatment guidelines establish a clear hierarchy among the various antibacterials used in the treatment of this disease and also the use of an age-stratified approach to AOM by recommending an observation strategy (‘watchful waiting’) without the use of antibacterials for some groups of patients with AOM. Infants and young children aged <2 years represent a target population characterized by a high incidence of AOM (and in particular of recurrent disease), lack of anatomic and physiologic maturity of airways, age-related immune humoral and cellular deficiencies, the presence of antibacterial-resistant pathogens, and a less efficient response to antibacterial treatment. Presently, the evidence accumulated in the literature is not sufficient to conclude that the role of antibacterials is only minimal in the management of AOM and that the watchful waiting policy is the most appropriate choice for patients aged <2 years with a certain AOM diagnosis. However, adherence to such a policy in patients with an uncertain or questionable AOM diagnosis and/or mild-to-moderate symptoms, in addition to its implementation in patients aged >2 years, could reduce substantially the use of antibacterials in children and play a major role in the strategy of decreasing antibacterial resistance.
Similar content being viewed by others
References
Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr Infect Dis J 1998; 17: 105–13
Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989; 160: 83–94
McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287: 3096–102
Kero P, Piekkala P. Factors affecting the occurrence of acute otitis media during the first year of life. Acta Paediatr Scand 1987; 76: 718–23
Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2,253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997; 99: 318–33
Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr 2001; 160: 407–13
Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr 1992; 120: 81–4
Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11: S7–11
Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1995; 14: 178–83
Jacobs MR, Dagan R, Appelbaum PC, et al. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998; 42: 589–95
Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 1991; 87: 466–74
Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media; metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 1994; 124: 355–67
Dowell SF, Marcy MS, Phillips WR, et al. Otitis media: principles of judicious use of antimicrobials agents. Pediatrics 1998; 101: 165–71
Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403–9
American Academy of Pediatrics and American Academy of Family Physicians. Clinical practice guideline: Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451–65
Casey J, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 2004; 23: 824–8
Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23: 829–33
van Buchem FL, Peeters MF, Van’t Hof MA. Acute otitis media: a new treatment strategy. BMJ 1985; 290: 1033–7
Froom J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997; 315: 98–102
Teele DW, Klein JO, Chase C, et al. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. J Infect Dis 1990; 162: 546–9
Marchand CD, Shurin PA, Turczyk VA, et al. Course and outcome of otitis media in early infancy: a prospective study. J Pediatr 1984; 104(6): 826–31
Lanphear BP, Byrd RS, Auinger P, et al. Increasing prevalence of recurrent acute otitis media among children in the United States. Pediatrics 1997; 99: E1
Auinger P, Lanphear BP, Kalkwarf HJ, et al. Trends in otitis media among children in the United States. Pediatrics 2003; 112: 514–20
Capra AM, Lieu TA, Black SB, et al. The costs of otitis media in a managed care population. Pediatr Infect Dis J 2000; 19: 354–5
Bondy J, Berman S, Glazner J, et al. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics 2000; 105(6): E72
Paradise JL. Otitis media in infants and children. Pediatrics 1980; 65: 917–43
Sanders EA, Tenbergen-Meekes AM, Voorhorst-Ogink MM, et al. Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent respiratory tract infections. Pediatr Res 1995; 37: 812–9
Ogra PL, Barenkamp SJ, DeMaria TF, et al. Recent advances in otitis media: 6. Microbiology and immunology. Ann Otol Rhinol Laryngol 2002; 111: 62–81
Grain MJ, Waltman WD, Turner JS, et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun 1996; 58: 3293–9
Yamanaka N, Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J Pediatr 1993; 122: 212–8
Yellon RF, Doyle WJ, Whiteside TL, et al. Cytokines, immunoglobulin and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg 1995; 121: 865–9
Turner D, Leibovitz E, Aran A, et al. Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J 2002; 21: 669–74
Carlin SA, Marchand CD, Shurin OA, et al. Host factors and early therapeutic response in acute otitis media. J Pediatr 1991; 118: 178–83
Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J 1997; 16: 463–70
Karma P, Luotononen P, Pukander J, et al. Haemophilus influenzae in acute otitis media. Acta Otolaryngol 1983; 95: 105–10
Kilpi T, Herva E, Kaijalainen T, et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20: 654–62
Block SL. Management of acute otitis media in the 1990s: the decade of resistant pneumococcus. Pediatr Drugs 1999; 1(1): 31–50
Leibovitz E, Raiz E, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J 1998; 17: 463–9
Rodriguez WJ, Schwartz RH. Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J 1999; 18: 942–4
Palmu AA, Herva E, Savolainen H, et al. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 2004; 83: 234–42
Klein JO. The ‘in vivo sensitivity test’ for acute otitis media revisited. Pediatr Infect Dis J 1998; 17: 774–5
Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997; 314: 1526–9
Takata G, Chan LS, Shekelle P, et al. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics 2001; 108(2): 239–47
Dagan R, McCracken Jr GH. Flaws in design and conduct of clinical trials in acute otitis media. Pediatr Infect Dis J 2002; 21: 894–902
Wald E. Acute otitis media: more trouble with the evidence. Pediatr Infect Dis J 2003; 22: 103–4
Harsten G, Prellenr K, Heldrup J, et al. Treatment failure in acute otitis media: a clinical study of children during their first three years of life. Acta Otolaryngol (Stockh) 1989; 108: 253–8
Appelman CL, Claessen JQ, Touw-Otten FW, et al. Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ 1991; 303: 1450–2
Dagan R, Leibovitz E. Bacterial eradication in the treatment of acute otitis media. Lancet Infect Dis 2002; 2: 593–604
Piglansky L, Leibovitz E, Raiz S, et al. The bacteriologic and clinical efficacy of high-dose amoxicillin as first-line therapy for acute otitis media in children. Pediatr Infect Dis J 2003; 22(5): 405–12
Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs azithromycin in acute otitis media. Pediatr Infect Dis J 2000; 19: 95–104
Hobermann A, Dagan R, Leibovitz E, et al. Large dosage amoxicillin/clavulanate compared with azithromycin for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J 2005; 24(6): 525–32
Leibovitz E, Piglansky L, Raiz S, et al. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone in the treatment of non-responsive acute otitis media. Pediatr Infect Dis J 2000; 19: 1040–5
Leiberman A, Leibovitz E, Piglansky L, et al. The bacteriologic and clinical efficacy of trimethoprim/sulfamethoxazole in the treatment of acute otitis media in children. Pediatr Infect Dis J 2001; 20: 260–4
Arguedas A, Sierra H, Soley C, et al. Activity of trimethoprim-sulfamethoxazole against middle ear fluid pathogens obtained from Costa Rican children with otitis media. Pediatr Infect Dis J 2005; 24: 839–41
Dagan R, Leibovitz E, Greenberg D, et al. Early eradication of pathogens from middle ear fluid is associated with improved clinical outcome. Pediatr Infect Dis J 1998; 17: 76–82
Leibovitz E, Piglansky L, Raiz S, et al. Bacteriological and clinical efficacy of oral gatifloxacin in the treatment of recurrent/non-responsive acute otitis media: an open-label, single center, non-comparative, double tympanocentesis study. Pediatr Infect Dis J 2003; 22: 1–7
Noel GJ, Leibovitz E, Dagan R, et al. Levofloxacin therapy for infants and young children with persistent or recurrent acute otitis media [abstract no. G-2081]. 43th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2004 Oct 30–Nov 2; Washington, DC: 267
Dagan R, Leibovitz E, Greenberg D, et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J 1998; 17: 776–82
Asher E, Greenberg D, Dagan R, et al. Failure to eradicate otitis media pathogens after 3–5 days of treatment is associated with higher relapse rate in children with initial improvement/cure [abstract no. G-2096]. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2004 Oct 30–Nov 2; Washington, DC: 271
Olson LC, Jackson MA. Only the pneumococcus. Pediatr Infect Dis J 1999; 81: 849–50
Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J 2004; 23: 1142–55
Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829–37
Leibovitz E, Dagan R, Arguedas A, et al. Evaluation of once daily cefdinir 25 mg/kg oral suspension in children with acute otitis media at risk of persistent or recurrent otitis media. Paper presented at 14th European Congress of Clinical Microbiology and Infectious Diseases; 2004 May 1–4; Prague
Arguedas A, Loaiza C, Soley C. Single dose azithromycin for the treatment of uncomplicated otitis media. Pediatr Infect Dis J 2004; 23(2): S108–14
Arguedas A, Emparanza P, Schwartz RH, et al. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J 2005; 24(2): 153–61
Cohen R, Levy C, Boucherat M, et al. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr 1998; 133: 634–9
Cohen R, Levy C, Boucherat M, et al. Five vs ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J 2000; 19: 458–63
Hoberman A, Paradise JL, Cohen R. Duration of therapy for acute otitis media. Pediatr Infect Dis J 2000; 19(5): 471–3
van Buchem FL. Therapy of acute otitis media: myringotomy, antibiotics, or neither? Lancet 1981; II: 883–7
Damoiseaux RAMJ, van Bulen FAM, Hoes AW, et al. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000; 420: 350–4
Little P, Gould C, Williamson I, et al. Pragmatic randomized controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001; 322: 336–42
Little P, Gould C, Moore M, et al. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomized trial. BMJ 2002; 325: 1–6
Le Saux N, Gaboury I, Baird M, et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. CMAJ 2005; 17: 335–41
McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics 2005; 115: 1455–65
Kaplan B, Wandstrat TL, Cunningham JR. Overall cost in the treatment of otitis media. Pediatr Infect Dis J 1997; 16: S9–11
Garbutt J, Jeffe DB, Shackelford P. Diagnosis and treatment of acute otitis media: an assessment. Pediatrics 2003; 112: 143–9
Finkelstein JA, Stille CJ, Rifas-Shiman SL, et al. Watchful waiting for acute otitis media: are parents and physicians ready? Pediatrics 2005; 115: 1466–73
Acknowledgements
No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leibovitz, E. Acute Otitis Media in Children Aged Less Than 2 Years. Pediatr-Drugs 8, 337–346 (2006). https://doi.org/10.2165/00148581-200608060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00148581-200608060-00002